Functional magnetic resonance imaging of pancreatic cancer: a feasibility and reproducibility study

Functional magnetic resonance imaging of pancreatic cancer: a feasibility and reproducibility study - MRI of pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41555

Enrollment

Registered

2012-09-21

Start date

2013-04-10

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Patients with pancreatic tumors, with histological or cytological proof of adenocarcinoma or a high suspicion on CT imaging. * Any tumor with a size * 1cm * WHO-performance score 0-2 * Written informed consent

Exclusion criteria

Exclusion criteria: * Any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol. * Contra-indications for MR scanning, including patients with a pacemaker, cochlear implant or neurostimulator; patients with non-MR compatible metallic implants in their eye, spine, thorax or abdomen; or an aneurysm clip in their brain; patients with severe claustrophobia. * Renal failure (GFR

Design outcomes

Primary

Measure	Time frame
Reproducibility of MRI parameters.	—

Secondary

Measure	Time frame
Correlation of MRI parameters with histology.	—

Countries

Netherlands

Outcome results